These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25868301)

  • 41. [Type 1 diabetes mellitus: pathogenesis, symptoms and therapy].
    Gero L
    Orv Hetil; 2010 Mar; 151(13):533-9. PubMed ID: 20304746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment options for paediatric diabetes.
    Verrotti A; Chiuri RM; Blasetti A; Mohn A; Chiarelli F
    Expert Opin Pharmacother; 2010 Oct; 11(15):2483-95. PubMed ID: 20666700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoglycemic effect of the rhizomes of Polygala senega in normal and diabetic mice and its main component, the triterpenoid glycoside senegin-II.
    Kako M; Miura T; Nishiyama Y; Ichimaru M; Moriyasu M; Kato A
    Planta Med; 1996 Oct; 62(5):440-3. PubMed ID: 8923811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic treatment of type 2 diabetes mellitus: realities and perspectives.
    Abdallah MP; Hirbli K
    J Med Liban; 1999; 47(4):233-7. PubMed ID: 10641451
    [No Abstract]   [Full Text] [Related]  

  • 45. [Glucides in the nutrition of diabetics].
    Maillard C
    Servir; 2002; 50(5):244-6. PubMed ID: 12494529
    [No Abstract]   [Full Text] [Related]  

  • 46. An analysis of the SEVEN system: have we reached the summit of needle-type sensor accuracy?
    Wentholt IM; DeVries JH
    J Diabetes Sci Technol; 2009 Sep; 3(5):1155-7. PubMed ID: 20144430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transient hyperopia and diabetes.
    Mehdizadeh M; Nowroozzadeh MH
    Ophthalmologica; 2010; 224(1):63; author reply 64. PubMed ID: 19707027
    [No Abstract]   [Full Text] [Related]  

  • 48. Severe iatrogenic hypoglycemia in type 2 diabetes mellitus.
    Cryer PE
    Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):4-5. PubMed ID: 17179922
    [No Abstract]   [Full Text] [Related]  

  • 49. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tenacious D. why beta cells are no match for the relentless persistence of type 2 diabetes.
    Curry A
    Diabetes Forecast; 2015; 68(5):38-41. PubMed ID: 26491753
    [No Abstract]   [Full Text] [Related]  

  • 51. State of safety.
    Tsai A
    Diabetes Forecast; 2015; 68(4):60-2, 65. PubMed ID: 26373221
    [No Abstract]   [Full Text] [Related]  

  • 52. Intensified glucose lowering in type 2 diabetes: don't throw the baby out with the bathwater.
    DeVries JH
    Diabetologia; 2011 Mar; 54(3):705-6; author reply 707-8. PubMed ID: 21127831
    [No Abstract]   [Full Text] [Related]  

  • 53. Type of diabetes mellitus: Does it matter to the clinician?
    Hoogwerf BJ
    Cleve Clin J Med; 2020 Feb; 87(2):100-108. PubMed ID: 32015063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early and intensive treatment: Glycaemic control in type 2 diabetes.
    Bailey CJ
    Diab Vasc Dis Res; 2006 Dec; 3(3):145-6. PubMed ID: 17160908
    [No Abstract]   [Full Text] [Related]  

  • 55. Diabetes: Time for reconciliation between cardiologists and diabetologists.
    Scheen AJ
    Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401
    [No Abstract]   [Full Text] [Related]  

  • 56. Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway.
    Litwinoff E; Hurtado Del Pozo C; Ramasamy R; Schmidt AM
    Clin Pharmacol Ther; 2015 Aug; 98(2):135-44. PubMed ID: 25974754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Approaches to treatment 1: How is type 2 diabetes actually treated?
    Bloomgarden ZT
    J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
    [No Abstract]   [Full Text] [Related]  

  • 58. Glucose-targeted therapy for subjects with type 2 diabetes mellitus: primum non nocere.
    Maggi D; Bordone C; Briatore L; Cheli V; Fontana L; Mazzucchelli C; Montecucco F; Adami G; Cordera R
    Eur J Clin Invest; 2017 Oct; 47(10):691-693. PubMed ID: 28746976
    [No Abstract]   [Full Text] [Related]  

  • 59. Glycemic variability: adverse clinical outcomes and how to improve it?
    Zhou Z; Sun B; Huang S; Zhu C; Bian M
    Cardiovasc Diabetol; 2020 Jul; 19(1):102. PubMed ID: 32622354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Physical activity and diabetes mellitus].
    Kemper M
    MMW Fortschr Med; 2010 Dec; 152(49-50):41-3. PubMed ID: 21298980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.